Vanguard ESG Developed Europe All Cap UCITS ETF
(V3EL) Vanguard ESG Developed Europe All Cap UCITS ETF - (EUR) Distributing
Related documents
About this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe All Cap Choice Index (the “Index”).
- The Fund attempts to track the performance of the Index by investing all, or substantially all, of its assets in the stocks that make up the Index in approximately the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process.
- The Index is a market-capitalisation-weighted index composed of large-, mid-, and small-cap stocks of companies located in developed markets in Europe. Market-capitalisation is the value of a company's outstanding shares in the market and shows the size of a company. The Index is constructed from the FTSE Developed Europe All Cap Index (the “Parent Index”) which is then screened for certain environmental, social, and governance (i.e. controversy-related) criteria which is independent of Vanguard.
- Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of their conduct or products on society and / or the environment, the Fund promotes certain environmental characteristics and social characteristics relating to social norms and standards.
- The Index methodology excludes stocks of companies that the sponsor of the Index determines (a) to be engaged or involved in specific activities of the supply chain for, and / or (b) derive revenue (above a threshold specified by the Index provider) from, certain activities relating to the following activities: (a) Vice Products (i.e., adult entertainment, alcohol, gambling, tobacco, cannabis); (b) Non-Renewable Energy (nuclear power, and fossil fuels (which includes: (i) companies that have greater than 50% ownership of companies that own proved or probable reserves in coal, oil or gas, (ii) oil and gas production and supporting services, (iii) coal extraction, production and supporting services, (iv) oil and gas and thermal coal power generation, (v) extraction of arctic oil and gas, and (vi) extraction of oil sands)); and (c) Weapons (chemical & biological weapons, cluster munitions, anti-personnel landmines, nuclear weapons, civilian firearms, and conventional military weapons).The Index provider defines what constitutes “involvement” in each activity. This may be based on percentage of revenue or any connection to a restricted activity regardless of the amount of revenue received, and will relate to specific parts of the supply chain.
- Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
- For the full investment strategy please review the prospectus.
Fund facts
Share class inception
Aug 16 2022
Listing date
Aug 18 2022
Investment structure
Irish UCITS
Share class assets'
Total assets
Risk indicator
Strategy
Index
Asset class
Equity
Investment Method
Physical
Index ticker
FGCDEAN
Benchmark
FTSE Developed Europe All Cap Choice Index
Dividend Schedule
Quarterly
Tax status
Austria, Germany, Switzerland and United Kingdom
Domicile
Ireland
Legal Entity
Vanguard Funds PLC
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at Sep 30 2026
Beta
R²
Alpha
Standard Deviation
Sharpe Ratio
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 976 | 962 | Sep 30 2026 |
| Median market capital | 51.6 B | 51.8 B | Sep 30 2026 |
| 16.4 x | 16.4 x | Sep 30 2026 | |
| 2.3 x | 2.3 x | Sep 30 2026 | |
| 14.2% | 14.2% | Sep 30 2026 | |
| 9.9% | 9.9% | Sep 30 2026 | |
| Portfolio turnover rate | -11.3% | — | Sep 30 2026 |
Market allocation
As at Sep 30 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 18.33% | 18.33% | 0.00% |
| Swiss | Europe | 16.44% | 16.44% | 0.00% |
| Germany | Europe | 12.71% | 12.70% | 0.01% |
| Netherlands | Europe | 11.41% | 11.41% | 0.00% |
| France | Europe | 8.99% | 8.99% | 0.00% |
| Suecia | Europe | 7.17% | 7.17% | 0.00% |
| España | Europe | 6.18% | 6.18% | 0.00% |
| Italia | Europe | 5.83% | 5.83% | 0.00% |
| Dinamarca | Europe | 3.55% | 3.55% | 0.00% |
| Finlandia | Europe | 2.05% | 2.06% | -0.01% |
| Belgium | Europe | 2.04% | 2.04% | 0.00% |
| Noruega | Europe | 1.28% | 1.28% | 0.00% |
| Polonia | Europe | 1.26% | 1.26% | 0.00% |
| Irlanda | Europe | 0.91% | 0.91% | 0.00% |
| Austria | Europe | 0.88% | 0.88% | 0.00% |
Top 10 Holdings
As at Sep 30 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 6.54652% | Technology | NL | €10,768,819.20 | 6,744 |
| Roche Holding AG | 2.75108% | Health Care | CH | €4,525,448.18 | 12,294 |
| Novartis AG | 2.50693% | Health Care | CH | €4,123,815.61 | 32,602 |
| AstraZeneca PLC | 2.28849% | Health Care | GB | €3,764,490.12 | 26,211 |
| Nestle SA | 2.19174% | Consumer Staples | CH | €3,605,342.63 | 44,978 |
| SAP SE | 1.92785% | Technology | DE | €3,171,258.46 | 17,081 |
| Banco Santander SA | 1.89180% | Financials | ES | €3,111,957.04 | 252,430 |
| Allianz SE | 1.68396% | Financials | DE | €2,770,060.20 | 6,654 |
| Banco Bilbao Vizcaya Argentaria SA | 1.48299% | Financials | ES | €2,439,468.06 | 98,326 |
| UBS Group AG | 1.39670% | Financials | CH | €2,297,526.45 | 54,081 |
Prices and distribution
Prices
NAV Price (EUR)
€6.92
EURChange
+€0.040.55% As at Oct 15 2026
Market price (GBP)
£5.87
Change
+£0.020.33% As at Oct 16 2026
NAV 52-week high
€7.14
As at Oct 16 2026
Market price 52-week high
£6.13
As at Oct 16 2026
NAV 52-week low
€6.10
As at Oct 16 2026
Market price 52-week low
£5.30
As at Oct 16 2026
NAV 52-week difference
€1.04
Change
+14.54% As at Oct 16 2026
Market price 52-week difference
£0.83
Change
+13.52% As at Oct 16 2026
Outstanding shares
5,040,874
As at Sep 30 2026
Discount
-£1.05
Change
-15.18% As at Oct 16 2026
Historical Prices
-
Inception date
Aug 16 2022
Listing date
Aug 18 2022
| Date | NAV (EUR) | Market price (GBP) |
|---|---|---|
| Oct 16 2026 | — | £5.8675 |
| Oct 15 2026 | €6.9175 | £5.8480 |
| Oct 14 2026 | €6.8799 | £5.8280 |
| Oct 13 2026 | €6.8437 | £5.7855 |
| Oct 12 2026 | €6.8489 | £5.7920 |
| Oct 09 2026 | €6.8140 | £5.7750 |
| Oct 08 2026 | €6.7557 | £5.7315 |
| Oct 07 2026 | €6.8301 | £5.7870 |
| Oct 06 2026 | €6.8873 | £5.8460 |
| Oct 05 2026 | €6.8390 | £5.7985 |
Distribution history
Distribution frequency
Quarterly
Historical performance Sep 30 2026
2.67%
| Type | Distribution amount (per unit) | Ex-dividend date | Record date | Payment date |
|---|---|---|---|---|
| Income | €0.0216 | Sep 17 2026 | Sep 18 2026 | Sep 30 2026 |
| Income | €0.1208 | Jun 18 2026 | Jun 19 2026 | Jul 01 2026 |
| Income | €0.0197 | Mar 19 2026 | Mar 20 2026 | Apr 01 2026 |
| Income | €0.0208 | Dec 18 2025 | Dec 19 2025 | Dec 31 2025 |
| Income | €0.0168 | Sep 18 2025 | Sep 19 2025 | Oct 01 2025 |
| Income | €0.1161 | Jun 19 2025 | Jun 20 2025 | Jul 02 2025 |
| Income | €0.0204 | Mar 20 2025 | Mar 21 2025 | Apr 02 2025 |
| Income | €0.0197 | Dec 12 2024 | Dec 13 2024 | Dec 27 2024 |
| Income | €0.0183 | Sep 12 2024 | Sep 13 2024 | Sep 25 2024 |
| Income | €0.1055 | Jun 13 2024 | Jun 14 2024 | Jun 26 2024 |
Purchase information
Currencies and stock exchanges
Listed currencies: EUR, GBP
Base currency:EUR
Exchanges: NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Borsa Italiana S.p.A.